FDMT vs LOW · rev $37.0K vs P/E 18, rev $86.29B
4D Molecular Therapeutics Inc (FDMT) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
FDMT currently screens at market cap $518.1M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the FDMT and LOW stock pages for the full models.
Not investment advice.